Sinusitis is a disease characterized by the inflammation of the sinus cavities, which leads to discomfort and disrupts day to day living. Montelukast, which is most often sold under the brand name singulair, shows great potential in treating sinus-related symptoms. Montelukast is a leukotriene receptor antagonist, which means that it targets leukotrienes (inflammatory mediator agents which play important roles in mucus production, sinus inflammation, and nasal congestion.) It works by blocking the action of these leukotrienes, which reduces inflammation and associated symptoms of sinusitis.
Montelukast
is often consumed daily in the evening, with or without food, depending on what
the patient’s healthcare provider says. ‘Montelukast for chronic sinusitis with
polyps’ is a systematic review and meta-analysis investigating the efficacy of
montelukast in patients who have chronic sinusitis based on polyp formation in
the nasal cavity. The research obtained showed that montelukast has a role in
reduction of symptoms and improvements in quality of life in individuals with chronic
sinusitis and nasal polyps.
Although
this medication is generally safe for consumption in most individuals, certain
groups and communities should exercise caution when using montelukast. This
includes pregnant women and people with allergies. The relation between
montelukast and pregnancy development is not very well established in the
medical field, which is why case-to-case analysis from a healthcare provider
becomes even more important. Those with known allergies to montelukast or other
components of the medicine shouldn’t take it.
Sometimes,
children who consume the medicine, may experience mood or behavioral changes.
It can even occur in adults. This is why, it’s important for healthcare
advisors and family members to observe if any changes occur in behavior of
people who consume the medicine. Along with that, people can also suffer from
headaches in some cases.
Comments
Post a Comment
Please add your name when you comment down below!